NewsSource: EClinCloud

Invitation | EClinCloud invites you to dTrial to discuss the future of digital clinical trials

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration

The pandemic has subsided, and now is the right time to reunite! The 2023 DIA China Digital Clinical Trial Innovation Forum (dTrial Forum) will be held on April 20–22 at DoubleTree by Hilton Suzhou Wuzhong.


As a gathering focused on digitalization in pharmaceutical clinical R&D, this year's dTrial is guided by the theme "combining digital technology with patient centricity to improve clinical trial innovation," bringing together experts in clinical trials and implemented practical cases in the technology field to highlight the latest advances in digital clinical trials and explore additional potential application scenarios.


As a promoter of digital clinical trials in China, EClinCloud has consistently dedicated itself to empowering new drug R&D through technological innovation and continuously supporting and accelerating the drug R&D process through digital and intelligent approaches. We look forward to exchanging ideas with leading experts in digital clinical trials at this conference and bringing more opportunities to the industry.



 Conference Information 


Conference Dates:

April 20–22, 2023


Conference Venue:

2nd Floor, DoubleTree by Hilton Suzhou Wuzhong

Address: Building 4, No. 99 Junyi Road, Wuzhong District, Suzhou


Organizers:

DIA China

DIA China Digital Health Community (DHC)


“

EClinCloud Keynote Presentation

Dr. Qin Long, Founder and CEO of EClinCloud, has been invited to attend, deliver a presentation, and participate as a panelist in the subsequent roundtable discussion. He looks forward to discussing cutting-edge industry trends with fellow experts.


Article illustration
Dr. Qin Long

Founder / CEO, EClinCloud


Session 104: Study Sites and Digital Service Providers

Time: Friday, April 21, 09:00–10:30

Location: 2nd Floor, DoubleTree by Hilton Suzhou Wuzhong | Jiangnan Hall 3

Topic: Digitally Connecting Hospitals and Trial Participants


“

EClinCloud Booth


Booth No.: A16


Article illustration



Gifts



We have prepared a lucky draw with a 100% win rate and gifts for you at our booth. We look forward to your visit!

Article illustration
Xiaomi Speaker
Article illustration
Wireless Charger
Article illustration
Felt Bag



Article illustration

Scan the QR code for more conference information

[dTrial 2023 Details]

Article illustration



EClinCloud looks forward to seeing you at dTrial!





About EClinCloud

EClinCloud is a technology company focused on clinical R&D, providing an integrated, interoperable all-in-one cloud platform for clinical trials (including technology products such as eCOA, CTMS, eTMF, EDC, and RTSM, and solutions such as scale management, linguistic validation, rater training, and data quality analysis) as well as clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, ophthalmology, and others). Combining frontier technology with life data to build a globally leading, patient-centric SaaS cloud platform for clinical evidence support, it helps domestic and international pharmaceutical companies and research institutions improve R&D efficiency and accelerate the market launch of drugs and medical devices, benefiting countless patients.




Article illustration

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.